EMD Millipore

The Merck KGaA subsidiary is launching the research-use only SMCxPRO later this year for protein detection using sandwich ELISAs paired with proprietary optical readout.

The deal gives EMD Millipore control of Singulex's single-molecule counting technology for research applications.

EMD Millipore, the life science division of Germany's Merck KGaA, has appointed Udit Batra as president and CEO effective May 15.

EMD Millipore has released five new immunoassay kits for use on Gyros' Gyrolab xP workstation.

NEW YORK (GenomeWeb News) – EMD Millipore today announced a clinical research, licensing, and joint development deal with Japan's Sysmex aimed at creating a flow cytometry platform for blood disorders.

NEW YORK (GenomeWeb News) – Promethera Biosciences today announced a collaboration with EMD Millipore to develop "an improved ready-to-use microfluidic perfusion liver assay."

NEW YORK (GenomeWeb News) – EMD Millipore, a division of Germany's Merck KGaA, announced this week that it has signed a deal to become the global distributor of Firefly BioWorks' SmartRNAplex microRNA profiling assay.
Specific terms of the deal were not disclosed.

Gyros this week announced a partnership with EMD Millipore to develop, manufacture, and commercialize immunoassay kits for the Gyrolab platform.

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Tuesday it has extended its global supply and distribution agreement with EMD Millipore.

EMD Millipore this week introduced its PureEpi Chromatin Preparation and Optimization Kit.

Pages

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.